23rd Cardiology Update Course 2019

      Date
      Feb 16, 2019 - Feb 20, 2019
      Location
      Davos, Switzerland
      Cardiology Update belongs to the major meetings in the field of cardiology in Europe. Following a long tradition this will be the 23rd Cardiology Update Course to be held every second year in Davos, Switzerland. The course is a joint educational programme from the Zurich Heart House / University of Zurich, the European Society of Cardiology (ESC), the Brigham and Women’s Hospital in Boston and the University of Michigan School of Medicine. A distinguished international teaching faculty contributes to an outstanding programme on latest scientific and therapeutic developments as well as on new intervention and treatment strategies in cardiology.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.